Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01737034
Other study ID # BMBF 0315681
Secondary ID
Status Completed
Phase N/A
First received November 26, 2012
Last updated November 29, 2012
Start date January 2011
Est. completion date August 2012

Study information

Verified date November 2012
Source University of Kiel
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The catch-up fat phenomenon is an evolutionary conserved physiological response to a starvationrefeeding cycle. It is characterized by long-term suppression of thermogenesis, reduced body protein regain and an increase in fat mass above basal level during refeeding. Clinically, it characterises weight cycling in overweight patients which is associated with increasing fat mass (visceral fat) and increased morbidity (e.g. insulin resistance, inflammation). In this project, the physiological, cellular and molecular mechanisms of this phenomenon will be investigated in humans, mice and C. elegans. It is hypothesized that refeeding a low GI (=glycemic index)- diet after weight loss prevents the catchup fat phenomenon and its sequelae. This translational research will provide comprehensive insights into the catch-up fat phenomenon as well as provide a suitable strategy of its prevention.


Description:

In a human intervention study, changes in physiological, metabolic, and neuroendocrine functions in response to weight cycling will be investigated under controlled conditions in normal weight subjects. The mechanisms of the catch-up fat phenomenon are analysed starting from stable energy balance followed by overfeeding, weight loss and weight regain following weight loss (refeeding). Changes in body composition (including ectopic fat), metabolism (resting energy expenditure, substrate oxidation rates, insulin resistance) and plasma hormone concentrations will be assessed. Fat tissue probes will be used to characterise key enzymes and signalling pathways, redox status and whole genome expression. Modulation of the hormonal response to weight cycling is brought about by varying macronutrient content and glycemic index of the diets. We hypothesize that, insulin and leptin resistance are explained by increased insulin secretion during the refeeding period. Both, adaptive thermogenesis as well as insulin and leptin resistance can be ameliorated by attenuation of the increase in insulin and leptin secretion during refeeding a low GI diet after weight loss.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- normal weight (BMI 20-24 kg/m2), normal fat mass

Exclusion Criteria:

- smoking, chronic diseases, drug intake, nutrient allergies, lactose intolerance, pacemaker, metalliferous implants

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
dietary intervention by varying GI diets
The human study intends to characterise the partitioning of weight gain during refeeding and to affect the catch-up fat phenomenon by the glycemic index (GI) of the diet.

Locations

Country Name City State
Germany Institute of Human Nutrition Kiel Schleswig-Holstein

Sponsors (1)

Lead Sponsor Collaborator
University of Kiel

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in body composition and energy metabolism after 3 weeks of underfeeding and 2 following weeks of refeeding Body composition measurement including BODPOD, QMR, BIA Energy Metabolism measurement using indirect calorimetry Body composition measurement after 4 and 6 study weeks No
See also
  Status Clinical Trial Phase
Completed NCT01754662 - Effects of Combining Cocoa and Soy in Type 2 Diabetes N/A
Withdrawn NCT01301768 - Group Education to Improve the Iodine Nutrition in Pregnancy: Cluster Randomized Trial N/A
Not yet recruiting NCT04494139 - Acceptability, Feasibility and Effectiveness of a Worksite Intervention to Lower Cardiometabolic Risk in South Africa N/A
Not yet recruiting NCT01084434 - Probiotic, Prebiotic and Synbiotic Effect on Immunity N/A
Completed NCT01079208 - Growth of Infants Fed New Starter Formula N/A
Completed NCT02266953 - The Use of a Communication Tool About Diet N/A
Completed NCT03367338 - Low-Phosphate Diet and Fibroblast Growth Factor-23 Level N/A